Skip to main content

Costa Carlos's Form 4 filing

Foghorn Therapeutics Inc. (FHTX) · filed Sep 24, 2024

Accession no.
0001562180-24-006927
Filed
Sep 24, 2024
Trade date
Sep 20-23, 2024
Filing delay
4 days
Rule 10b5-1 plan
Checked

This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $367.7K. It was filed 4 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Costa CarlosCIK 0001939167Officer (Chief People Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Sep 20, 2024Common StockMOption exerciseAcquired+35,756$3.72+$133,012.3235,756Direct
Sep 20, 2024Common StockSSaleDisposed−35,756$10.04−$358,990.240Direct
Sep 23, 2024Common StockMOption exerciseAcquired+857$3.72+$3,188.04857Direct
Sep 23, 2024Common StockSSaleDisposed−857$10.17−$8,715.690Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Sep 20, 2024Common StockMOption exerciseDisposed−35,756$0.00$040,646Direct
Sep 23, 2024Common StockMOption exerciseDisposed−857$0.00$039,789Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)